Market Overview:
The global MRSA antibiotics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of MRSA infections, rising demand for novel antibiotics, and growing awareness about antibiotic resistance. The global MRSA antibiotics market is segmented on the basis of type into vancomycin, teicoplanin, linezolid, and cubicin. Vancomycin held the largest share of the global MRSA antibiotics market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high efficacy against various strains of bacteria including MRSA and low risk for development of resistance. Teicoplanin is projected to be the fastest-growing type segment during the forecast period owing to its high efficacy against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA).
Product Definition:
MRSA Antibiotics are a specific type of antibiotics that are used to treat infections caused by methicillin-resistant Staphylococcus aureus, or MRSA. MRSA is a type of bacteria that is resistant to many common antibiotics, so it is important to use specifically MRSA antibiotics to treat these infections.
Vancomycin:
Vancomycin is an antibiotic drug and was first developed in the early 1960s. It was approved by the U.S. FDA for treatment of infections in 1965, and gained prominence as an anti-staphylococcal agent during the 1970s and 1980s; it has been used extensively as a second line of defense against community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections since then.
Teicoplanin:
Teicoplanin is a antibiotic used to treat severe bacterial infections. It works by killing the bacteria, mainly through the destruction of their cell walls. The drug has activity against staphylococci and certain mycobacteria species, including tuberculosis and leprosy.
Application Insights:
The adults segment held the largest share of 60.0% in 2017. The rising prevalence of chronic diseases, especially diabetes, and the increasing number of surgeries are among the major factors driving demand for mrsa antibiotics in this segment. According to a study conducted by CDC, it was estimated that diabetic population would reach nearly 23% of U.S. population by 2030 if proper measures were not taken to control this disease which is also a major factor driving demand for mrsa antibiotics in developed countries such as U.K.
Regional Analysis:
North America dominated the global market in 2017. This is due to the high prevalence of multi-drug resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB). In addition, linezolid was recently approved by the U.S. FDA for treatment of MDR and XDRTB, which will further boost its usage in this region over the forecast period. Asia Pacific is expected to be one of the fastest growing regions during the forecast period owing to increasing incidence rates of multidrug resistant infections as well as extensive research & development activities by various companies pertaining to new generation antibiotics that are effective against MRSA strains with increased resistance levels towards other antibiotics such as vancomycin, teicoplanin, etc.
Growth Factors:
- Increasing incidence of hospital-acquired infections (HAIs) due to MRSA
- Rising demand for better and newer antibiotics to treat MRSA infections
- Growing number of initiatives by public health organizations and governments to prevent the spread of MRSA infections
- Technological advancements in the field of antibiotic research and development that are expected to lead to the discovery of novel antibiotics against MRSA infection 5. Emergence of multidrug-resistant strains of MRSA
Scope Of The Report
Report Attributes
Report Details
Report Title
MRSA Antibiotics Market Research Report
By Type
Vancomycin, Teicoplanin, Linezolid, Cubicin, Others
By Application
Adults, Children
By Companies
Pfizer, Sanofi, Novartis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global MRSA Antibiotics Market Report Segments:
The global MRSA Antibiotics market is segmented on the basis of:
Types
Vancomycin, Teicoplanin, Linezolid, Cubicin, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Sanofi
- Novartis
Highlights of The MRSA Antibiotics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vancomycin
- Teicoplanin
- Linezolid
- Cubicin
- Others
- By Application:
- Adults
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the MRSA Antibiotics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MRSA antibiotics are a type of antibiotic that is used to treat infections caused by the MRSA bacteria. These antibiotics work by killing the MRSA bacteria.
Some of the key players operating in the mrsa antibiotics market are Pfizer, Sanofi, Novartis.
The mrsa antibiotics market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 MRSA Antibiotics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 MRSA Antibiotics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 MRSA Antibiotics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the MRSA Antibiotics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global MRSA Antibiotics Market Size & Forecast, 2018-2028
4.5.1 MRSA Antibiotics Market Size and Y-o-Y Growth
4.5.2 MRSA Antibiotics Market Absolute $ Opportunity
Chapter 5 Global MRSA Antibiotics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 MRSA Antibiotics Market Size Forecast by Type
5.2.1 Vancomycin
5.2.2 Teicoplanin
5.2.3 Linezolid
5.2.4 Cubicin
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global MRSA Antibiotics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 MRSA Antibiotics Market Size Forecast by Applications
6.2.1 Adults
6.2.2 Children
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global MRSA Antibiotics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 MRSA Antibiotics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America MRSA Antibiotics Analysis and Forecast
9.1 Introduction
9.2 North America MRSA Antibiotics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America MRSA Antibiotics Market Size Forecast by Type
9.6.1 Vancomycin
9.6.2 Teicoplanin
9.6.3 Linezolid
9.6.4 Cubicin
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America MRSA Antibiotics Market Size Forecast by Applications
9.10.1 Adults
9.10.2 Children
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe MRSA Antibiotics Analysis and Forecast
10.1 Introduction
10.2 Europe MRSA Antibiotics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe MRSA Antibiotics Market Size Forecast by Type
10.6.1 Vancomycin
10.6.2 Teicoplanin
10.6.3 Linezolid
10.6.4 Cubicin
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe MRSA Antibiotics Market Size Forecast by Applications
10.10.1 Adults
10.10.2 Children
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific MRSA Antibiotics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific MRSA Antibiotics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific MRSA Antibiotics Market Size Forecast by Type
11.6.1 Vancomycin
11.6.2 Teicoplanin
11.6.3 Linezolid
11.6.4 Cubicin
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific MRSA Antibiotics Market Size Forecast by Applications
11.10.1 Adults
11.10.2 Children
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America MRSA Antibiotics Analysis and Forecast
12.1 Introduction
12.2 Latin America MRSA Antibiotics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America MRSA Antibiotics Market Size Forecast by Type
12.6.1 Vancomycin
12.6.2 Teicoplanin
12.6.3 Linezolid
12.6.4 Cubicin
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America MRSA Antibiotics Market Size Forecast by Applications
12.10.1 Adults
12.10.2 Children
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) MRSA Antibiotics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) MRSA Antibiotics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) MRSA Antibiotics Market Size Forecast by Type
13.6.1 Vancomycin
13.6.2 Teicoplanin
13.6.3 Linezolid
13.6.4 Cubicin
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) MRSA Antibiotics Market Size Forecast by Applications
13.10.1 Adults
13.10.2 Children
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 MRSA Antibiotics Market: Competitive Dashboard
14.2 Global MRSA Antibiotics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Sanofi
14.3.3 Novartis
